Results 131 to 140 of about 18,555 (176)
Treatment of dry age-related macular degeneration: A review
Clinical and Experimental Ophthalmology, 2023 AbstractAge‐related macular degeneration is a global disease with a significant societal impact. The advent of anti‐vascular endothelial growth factor therapy (anti‐VEGF) has revolutionised the treatment of neovascular age‐related macular degeneration (nAMD).
Shenouda Girgis, Lawrence R Lee
exaly +5 more sources
Imaging Characteristics of Dry Age-Related Macular Degeneration
Seminars in Ophthalmology, 2011 To review the current literature regarding the imaging characteristics of dry age-related macular degeneration (AMD) lesions, with a special focus on drusen and geographic atrophy imaging. We also explore the role of novel approach of hyperspectral imaging in AMD.Review of current literature as well as findings in a small group of patients imaged with ...
Theodore Smith +2 more
exaly +4 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Dry age-related macular degeneration in the Japanese population
Japanese Journal of Ophthalmology, 2021To elucidate the clinical characteristics of eyes with dry age-related macular degeneration (AMD) in Japan.Retrospective.We performed a nationwide survey of dry AMD. A questionnaire on dry AMD was sent to 3,801 major hospitals and eye clinics nationwide.
Akitaka, Tsujikawa +8 more
openaire +2 more sources
Neutrophil-Lymphocyte Ratios in Dry Age-Related Macular Degeneration
Ocular Immunology and Inflammation, 2022Inflammation plays a role in the etiopathogenesis of age-related macular degeneration (AMD). A retrospective case-control study was conducted to assess the significance of the neutrophil-lymphocyte ratio (NLR) as a systemic inflammatory indicator in dry AMD.
Sannan Naif +5 more
openaire +2 more sources
Dobesilate for dry age-related macular degeneration ()
Journal of Biomedical Science and Engineering, 2013 We have evaluated the effects of intravitreal dobesilate, a synthetic fibroblast growth factor inhibitor, in patients with dry age-related macular degeneration, an inflammatory-related retinal disease without available treatment up to date. 36 eyes from 36 patients with dry age-related macular degeneration were treated with a single intravitreal ...
Javier Angulo +2 more
exaly +3 more sources
Association of NLRPs with pathogenesis of dry age-related macular degeneration
International Ophthalmology, 2023Age-related macular degeneration (AMD) is the leading cause of blindness in the elderly population, and Dry AMD is the most common clinical subtype. However, effective measures for the early diagnosis and treatment of dry AMD have not been proposed. In recent years, NOD-like receptors (NLRs) have received attention in the study of AMD as an important ...
Yiyun, Zeng +3 more
openaire +2 more sources
Inflammation in Dry Age-Related Macular Degeneration
Ophthalmologica, 2007<i>Purpose:</i> To summarize the current information regarding the role of immune and inflammatory response in the pathogenesis of dry age-related macular degeneration (ARMD). <i>Methods:</i> A Pubmed search was conducted of the period January 1999 to 2005.
openaire +2 more sources
Treatment of nonexudative (dry) age-related macular degeneration
Current Opinion in Ophthalmology, 2006The purpose of this report is to review the recent literature and summarize currently available and potential new treatment options for nonexudative age-related macular degeneration.High-dose vitamin supplementation may have some associated systemic toxicity. It is important to check that the patient is taking beta-carotene and not vitamin A as retinal
Mark J, Donaldson, Jose S, Pulido
openaire +2 more sources